This document discusses anti-adrenergic drugs, which antagonize the receptor action of adrenaline. It classifies anti-adrenergic drugs into alpha-blockers and beta-blockers, and describes their mechanism of action in blocking or inhibiting catecholamines. It provides details on the pharmacokinetics of propranolol and pharmacological actions of beta-blocking drugs on the cardiovascular, renal, central nervous and other body systems. Finally, it lists common uses such as for hypertension and myocardial infarction, and potential adverse drug reactions including bradycardia and nightmares.